FDA
approval
· 2023-06-16
FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
The FDA approved Lupin Pharmaceuticals' supplemental application for levetiracetam, enabling the marketing of a generic version of the drug. The approval confir…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)